AUD 0.05
(1.89%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 | - AUD | 0.0% |
2023 | - AUD | 0.0% |
2022 | - AUD | 0.0% |
2021 | - AUD | -100.0% |
2020 | 54.41 Thousand AUD | 0.0% |
2019 | - AUD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 FY | - AUD | 0.0% |
2024 Q2 | - AUD | 0.0% |
2024 Q4 | - AUD | 0.0% |
2024 Q3 | - AUD | 0.0% |
2024 Q1 | - AUD | 0.0% |
2023 FY | - AUD | 0.0% |
2023 Q4 | - AUD | 0.0% |
2023 Q3 | - AUD | 0.0% |
2023 Q2 | - AUD | 0.0% |
2023 Q1 | - AUD | 0.0% |
2022 Q2 | - AUD | 0.0% |
2022 FY | - AUD | 0.0% |
2022 Q4 | - AUD | 0.0% |
2022 Q3 | - AUD | 0.0% |
2022 Q1 | - AUD | 0.0% |
2021 Q4 | - AUD | 0.0% |
2021 Q3 | - AUD | 0.0% |
2021 Q1 | - AUD | 0.0% |
2021 FY | - AUD | -100.0% |
2020 FY | 54.41 Thousand AUD | 0.0% |
2019 FY | - AUD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Mayne Pharma Group Limited | 31.64 Million AUD | 100.0% |